Events & Training for July 2015

Peptides

08 July 2015 - 09 July 2015

The conference sets the stage for attendees to gain valuable insight into innovative topics such as cyclic peptides: R&D platforms, manufacture and stability, oral delivery of peptides, cell permeable peptide therapeutics for cancer treatments and Development of Peptides for the Clinic. Along with this, the programme will provide insight into formulating solutions for delivery and round table discussions on case studies demonstrating the translation of R&D peptides to the clinic. Keynote speakers include: • Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune • Jörg vollmer, CEO, Nexigen • Stephen Hale, SVP Biological Sciences, Ensemble Therapeutics • Dan Teufel, Head of Chemistry, Bicycle Therapeutics • Juan J. diaz-Mochon, Group Leader NANOCHEMBIO research team, Genyo • Renata Zbozien, Research Manager, Haemostatix

Marriott Regents Park Hotel, London, UK

Infectious Diseases World Summit

08 July 2015 - 10 July 2015

In recent years, the field of infectious diseases has faced repeated challenges, and areas such as pricing and reimbursement, regulatory, and the discovery of novel antibiotics have yet to be overcome. However, recent deals and the reemergence of big pharma in the space has signaled that the landscape of infectious diseases is shifting: why is there a renewed interest in this field? What will it mean for biotech companies, government agencies, and other players? This Summit seeks to highlight all stages of the field, from research and novel therapeutics, to commercialization aspects and market activity. Colleagues from academia, industry, and government will gather at the interface of infectious diseases drug development to address current issues and find solutions to move the field forward into the future.

Hyatt Regency, Boston, MA, USA

Allergies

08 July 2015 - 09 July 2015

Allergies 2015 will focus on developments of novel vaccines and adjuvants for immunotherapy, along with a strong focus on allergy clinical trials and pharmacovigilance to gain a solid understanding of the current requirements and obligations in the development of immunotherapy products. 5 Reasons Why You Should Attend: • Discovering novel strategies being implemented in the field of vaccines and adjuvants for immunotherapy • Overcoming challenges faced in the development of clinical trials for allergen therapeutics including trial policies and paediatrics • Creating new solutions for the delivery of therapeutics to increase patient quality of life and increase compliance to provide an optimal treatment strategy • Highlighting new pathways involved in the development of allergy to provide a better understanding of new targets for drug development and targeting • Reviewing new developments in the field of allergy immunotherapeutics to provide an insight into future development prospects.

Marriott Hotel, Regents Park, London, UK